Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

A conversation with Stacy Loeb, MD Professor of Urology and Population Health at NYU Langone Health and the Manhattan VA.

COLONIE — Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

What to Watch: In Theaters and On Streaming. Link to What to Watch: In Theaters and On Streaming. 5 TV and Streaming Shows You Should Binge-Watch in January Link to 5 TV and Streaming Shows You ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...

New research by a team of Indiana University School of Medicine scientists and their collaborators has uncovered a novel vulnerability in prostate cancer animal models that starves prostate tumors ...

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...